Lipocine Inc expected to post a loss of 2 cents a share - Earnings Preview

Lipocine

05/05/2023 19:35

* Lipocine Inc  LPCN.OQ   LPCN.O  is expected to show a rise
in
quarterly revenue when it reports  results on May 8
(estimated). 
    * The Salt Lake City Utah-based  company is expected to
report
revenue of $777 thousand, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Lipocine Inc is for
a
loss of 2 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lipocine
Inc is
$4​, above​ its last closing price of $0.25. ​​​

This summary was machine generated May 5 at 18:35 GMT.  All
figures in US dollars  unless otherwise stated